Market Place
Filter By Unselect All
Sub Category Unselect See All
Overview (16)
Country Unselect See All
Companies Unselect See All
APC Ltd (1)
AXYNTIS Group (1)
Eurofins CDMO (1)
Flamma Spa (1)
Grace (1)
LEBSA (1)
Microchem SRL (1)
Pfanstiehl, Inc (1)
Servier CDMO (1)
ZACH SYSTEM SPA (1)
Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
Complete Development of API 
API & Drug Product Development >> API Development >> Overview
LEBSA offers an end-to-end partnership for custom API development, scale-up and manufacturing with a flexible multipurpose EU GMP Pilot Plant, from grams to tones, with a client centric approach.
Website
CDMO Capabilities for APIs
API & Drug Product Development >> API Development >> Overview
An offer complying with Good Manufacturing Practices (GMP), closely monitored by the Quality Insurance and Regulatory Affairs services: Laboratory, Kilolab, Pilot, industrial production and preparatory chromatography services.
API Development
API & Drug Product Development >> API Development >> Overview
Biophore, an established pharmaceutical company, is engaged in the development and manufacturing of niche pharmaceutical products for the generic industry. Biophore has emerged as a trusted partner in the generic industry across US, Europe and other regulated markets.
Fate & Purge Services
API & Drug Product Development >> API Development >> Overview
Eurofins CDMO has a strong experience in impurity control strategy from IND through to commercial stages and have demonstrated track-record in the design and execution of fate and purge studies.
Development of APIs
API & Drug Product Development >> API Development >> Overview
Drug’On Pharma Switzerland was the last company to be set up in the Orofino Pharmaceuticals Group. The Group bought out the ex Knoll and Abbott manufacturing site in Liestal,Switzerland. The chemical manufacturing site produces active pharmaceuticals ingredients (API) and intermediates.
Development of High-Value/Low-Volume Niche-Complex APIs
API & Drug Product Development >> API Development >> Overview
Sequent has invested in facilities with an objective of creating an integrated, flexible unit capable of manufacturing several niche & complex APIs. The manufacturing facalities are capable of meeting the growing demand of our key products in the USFDA and WHO regulated markets.
Micronization
API & Drug Product Development >> API Development >> Overview
Our contract micronization services have been refined and improved based on actual in-depth experience gained from our daily processing operations. Our state-of-the art material handling service applies micronization technology based on this combination of improved equipment and practiced,
R&D & Manufacturing
API & Drug Product Development >> API Development >> Overview
Kimia Biosciences' strength lies in focus on R & D where we propose to continuously invest and innovate to be in line with the global technological advancements and offer most cost effective processes to our pharmaceutical fraternity in our country as well as globally.
API Development 
API & Drug Product Development >> API Development >> Overview
Eurofins CDMO's development team operates well-equipped laboratories to handle the most complex API development challenges.
R & D of APIS
API & Drug Product Development >> API Development >> Overview
Our experienced process development chemists are an asset to our customers regardless of their size - virtual, small, mid-size, or large pharma/biotech. The scientists in the Flamma Italy R&D group and the Dalian Flamma Bioscience R&D group provide optimal service to complete projects.